[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336622-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336622-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","triggering-receptor-expression-on-myeloid-cells-1-trem1-promoter-hypomethylation-and-its-overexpression-associated-with-poor-survival-of-cancer-patients-pan-cancer-analysis","Triggering Receptor Expression on Myeloid Cells-1 (TREM1) Promoter Hypomethylation and Its Overexpression Associated With Poor Survival of Cancer Patients - Pan-Cancer Analysis","","The study investigates triggering receptor expression on myeloid cells-1 (TREM1) in cancer, focusing on how promoter methylation relates to mRNA overexpression and patient survival. TREM1 is an immunoglobulin-superfamily receptor implicated in infectious, autoimmune, and cancer settings, yet the mechanism controlling TREM1 mRNA expression remains unclear. Using TCGA cohorts and UALCAN analyses, methylation and expression are evaluated across cancers, with Kaplan-Meier survival testing. Results show hypomethylation, negative methylation-expression correlation, and worse prognosis with higher TREM1 expression, suggesting prognostic and biomarker potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/triggering-receptor-expression-on-myeloid-cells-1-trem1-promoter-hypomethylation-and-its-overexpression-associated-with-poor-survival-of-cancer-patients-pan-cancer-analysis/336622/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/triggering-receptor-expression-on-myeloid-cells-1-trem1-promoter-hypomethylation-and-its-overexpression-associated-with-poor-survival-of-cancer-patients-pan-cancer-analysis/336622.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this pan-cancer analysis?","Question",{"text":63,"@type":64},"To analyze the promoter methylation level of TREM1 and determine how it relates to TREM1 overexpression across cancers and patient outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets and tools were used to study TREM1 methylation, expression, and survival?",{"text":68,"@type":64},"Analyses used The Cancer Genome Atlas (TCGA) cohort, with UALCAN for TCGA-based data analysis. Survival associations were assessed using Kaplan-Meier (KM) plots from the TCGA dataset.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship did the study find between TREM1 promoter methylation and mRNA expression?",{"text":72,"@type":64},"Promoter methylation analysis showed TREM1 is hypomethylated in cancers, leading to significantly overexpressed TREM1 mRNA, with a negative correlation between methylation and expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336622,1790186779,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Received 04/15/2024  \nReview began 05/13/2024  \nReview ended 07/03/2024  \nPublished 07/16/2024  \n© Copyright 2024  \nRuskin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.64640  \nOpen Access Original Article  \nPublished via Saveetha Institute of Medical and Technical Sciences  \nTriggering Receptor Expression on Myeloid Cells- 1 (TREM1) Promoter Hypomethylation and Its Overexpression Associated With Poor Survival of Cancer Patients: A Pan-Cancer Analysis  \nPinky Ruskin 1, Chandra Pandi 2, Balachander Kannan 2, Anitha Pandi 3, Smiline Girija A. S. 1 , Vijayashree Priyadharsini Jayaseelan 3, Paramasivam Arumugam 2  \n1. Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND 2. Molecular Biology Lab, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND 3. Clinical Genetics Lab, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND  \nCorresponding author: Paramasivam Arumugam, [paramasivama.sdc@saveetha.com](paramasivama.sdc@saveetha.com)  \nAbstract  \nBackground  \nTriggering receptor expression on myeloid cells-1 (TREM1) belongs to the immunoglobulin superfamily and is implicated in various conditions, including infectious and non-infectious diseases, autoimmune disorders, and cancer. Notably, TREM1 is significantly dysregulated in numerous cancer types. However, the underlying mechanism driving TREM1 mRNA expression in cancers remains unclear.  \nObjective  \nThis study aims to analyze the promoter methylation level ofTREM1 and its overexpression with cancer.  \nMethods  \nThis study utilized The Cancer Genome Atlas (TCGA) cohort to analyze the methylation and expression levels ofTREM1 in cancers. The University of ALabama at Birmingham CANcer (UALCAN) database facilitated data analysis from the TCGA dataset. Additionally, survival analysis was conducted using the TCGA dataset via Kaplan-Meier (KM) plots to identify significant associations with prognosis.  \nResults  \nPromoter methylation analysis revealed that TREM1 is hypomethylated in cancers, resulting in significantly overexpressed mRNA across various cancer types. This methylation and expression showed a negative correlation. Furthermore, high TREM1 mRNA expression was linked to poor prognosis in several cancers.  \nConclusion  \nTREM1 gene expression negatively correlates with promotor DNA methylation and is associated with poor survival. It may serve as a prognostic marker and biomarker for various cancers. Future research should focus on further validation and antitumor immunity to elucidate its oncogenic role in cancers.  \nCategories: Genetics, Oncology  \nKeywords: therapeutic target, novel biomarker, dna methylation, hnscc, trem1  \nIntroduction  \nCancer remains one of the most devastating diseases of the 20 th and 21st centuries. In 2022, 20 million new cases and 9 .7 million deaths were documented worldwide, and exposure to various carcinogens has become increasing. Cancers can develop from any organ or body structure and are made up of microscopic cells that have lost the ability to stop growing [1] . Cancerous cells transition from normal cells due to the failure of the body 's immune cells to detect and eliminate newly formed cancer cells when they are present in small numbers [2] . Genetic and epigenetic alternations also play a major role in cancer development. In genetic alternations, missense mutations, insertions, deletions, copy number variations, and recombination of DNA are involved [3] . Oncogenes and other inflammatory g","cbCaimdTItNissNz","https://ap.wps.com/l/cbCaimdTItNissNz","pdf",3087026,11,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n# How to cite this article","[{\"question\":\"What is the main objective of this pan-cancer analysis?\",\"answer\":\"To analyze the promoter methylation level of TREM1 and determine how it relates to TREM1 overexpression across cancers and patient outcomes.\"},{\"question\":\"Which datasets and tools were used to study TREM1 methylation, expression, and survival?\",\"answer\":\"Analyses used The Cancer Genome Atlas (TCGA) cohort, with UALCAN for TCGA-based data analysis. Survival associations were assessed using Kaplan-Meier (KM) plots from the TCGA dataset.\"},{\"question\":\"What relationship did the study find between TREM1 promoter methylation and mRNA expression?\",\"answer\":\"Promoter methylation analysis showed TREM1 is hypomethylated in cancers, leading to significantly overexpressed TREM1 mRNA, with a negative correlation between methylation and expression.\"}]","Triggering Receptor Expression on Myeloid Cells-1 (TREM1) Promoter Hypomethylation and Its Overexpression Associated With Poor Survival of Cancer Patients - Pan-Cancer Analysis | PDF",1790015900,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38d9bbd6bd36a02d8758d7e3bf9e20be.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8871a77a10b2060f184f55a3e4facf99.webp",982,1389,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4ee7a000c95fc6fecadf95f525f8aa4.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5192eb60e8e23f6638437b40ba508df.webp",980,1386]